Free Access
Med Sci (Paris)
Volume 22, Number 2, Février 2006
Page(s) 115 - 117
Section Nouvelles
Published online 15 February 2006
  1. The Huntington’s disease collaborative research group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993; 72 : 971–83. [Google Scholar]
  2. Mangiarini L, Sathasivam K, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87 : 493–506. [Google Scholar]
  3. Davies SW, Turmaine M, Cozens BA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997; 90 : 537–48. [Google Scholar]
  4. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997; 277 : 1990–3. [Google Scholar]
  5. Arrasate M, Mitra S, Schweitzer ES, et al. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004; 431 : 805–10. [Google Scholar]
  6. Vonsattel JP, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 1985; 44 : 559–77. [Google Scholar]
  7. Jakel RJ, Maragos WF. Neuronal cell death in Huntington’s disease : a potential role for dopamine. Trends Neurosci 2000; 23 : 239–45. [Google Scholar]
  8. Cyr M, Beaulieu JM, Laakso A, et al. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proc Natl Acad Sci USA2003; 100 : 11035–40. [Google Scholar]
  9. Aylward EH, Codori AM, Rosenblatt A, et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington’s disease. Mov Disord 2000; 15 : 552–60. [Google Scholar]
  10. Luo Y, Umegaki H, Wang X, et al. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem 1998; 273 : 3756–64. [Google Scholar]
  11. Reiner A, Albin RL, Anderson KD, et al. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 1988; 85 : 5733–7. [Google Scholar]
  12. Li H, Li SH, Yu ZX, et al. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington’s disease mice. J Neurosci 2001; 21 : 8473–81. [Google Scholar]
  13. Charvin D, Vanhoutte P, Pages C, et al. Unraveling a role for dopamine in Huntington’s disease : the dual role of reactive oxygen species and D2 receptor stimulation. Proc Natl Acad Sci USA 2005; 102 : 12218–23. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.